Table 1.
Malignancy, primary location | N (% of total) | Person-year | Event | Rate* | SIR# (95% C.I.) |
---|---|---|---|---|---|
Total | 1,105,009 (100.00) | 6383055.73 | 19,906 | 312 | 1.31 (1.30–1.33) |
Head and neck | 85,950 (7.78) | 521311.01 | 1,990 | 382 | 2.58 (2.37–2.80) |
Digestive | 394,258 (35.68) | 1981200.05 | 5,990 | 302 | 1.50 (1.39–1.61) |
Respiratory | 131,116 (11.87) | 543125.91 | 4,842 | 892 | 5.45 (4.92–5.97) |
Bone, skin and soft tissues | 47,119 (4.26) | 306022.29 | 1,012 | 331 | 1.68 (1.50–1.86) |
Breast | 130,717 (11.83) | 907147.77 | 840 | 93 | 0.85 (0.75–0.95) |
Urinary tract | 55,316 (5.01) | 343241.16 | 1,155 | 336 | 1.85 (1.50–2.20) |
Female genital tract | 107,556 (9.73) | 877298.75 | 824 | 94 | 0.83 (0.76–0.90) |
Male genital tract and prostate | 48,773 (4.41) | 305098.64 | 1,359 | 445 | 1.29 (1.06–1.51) |
Hematology | 49,002 (4.43) | 271294.65 | 1,327 | 489 | 3.70 (3.46–3.93) |
Other cancer | 55,202 (5.00) | 327314.50 | 567 | 173 | 1.59 (1.45–1.74) |
*Rate: per 100,000 person years.
#Standardized year 2011.